It was reported via journal article: title: regression of barrett¿s esophagus after magnetic sphincter augmentation: intermediate-term results.Author: colin p.Dunn, justin c.Henning, jason a.Sterris, paul won, caitlin houghton, nikolai a.Bildzukewicz, john c.Lipham.Citation: doi: https://doi.Org/10.1007/s00464-020-08074-6.This is a retrospective review of 87 patients (male n=55, median bmi was 26.95) with biopsy-proven barrett¿s esophagus who underwent magnetic sphincter augmentation with linx device (ethicon) between april 2007 and september 2019.Perioperative complications of intra-operative bleeding (n=1) which required additional port placement for control (though no blood was transfused) was reported and a patient was readmitted for dysphagia (n=1) which was resolved with a course of steroids were reported.Postoperatively, patients had unchanged results of their latest biopsy (n=75%) and some patients showed who had originally short-length barret¿s had lengthening of their barrett¿s segment (n=5).Msa reduces esophageal acid exposure and can lead to reduction or resolution of barrett¿s esophagus.Msa is also effective at preventing progression of metaplasia to dysplasia or neoplasia.This effect remains consistent even after 2 years of follow-up.
|